tiprankstipranks
Veeva Systems Inc (CH:VEE)
NYSE:VEE
Switzerland Market
VEE
Veeva Systems
RESEARCH TOOLSreports

Veeva Systems (VEE) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

VEE Analyst Ratings

Moderate Buy
22Ratings
Moderate Buy
15 Buy
6 Hold
1 Sell
Based on 22 analysts giving stock ratings to
Veeva
Systems
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VEE Stock 12 Month Forecast

Average Price Target

$193.53
Based on 22 Wall Street analysts offering 12 month price targets for Veeva Systems in the last 3 months. The average price target is $193.53 with a high forecast of $275.94 and a low forecast of $133.91. The average price target represents a ― change from the last price of ―.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"123":"$123","276":"$276","161.25":"$161.3","199.5":"$199.5","237.75":"$237.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":275.944459,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$275.94</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":193.52634190749998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$193.53</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":133.91422275,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$133.91</span>\n  </div></div>","useHTML":true}}],"tickPositions":[123,161.25,199.5,237.75,276],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2025","6":"Dec<br/>2025","9":"Mar<br/>2026","12":"Jun<br/>2026","25":"Jun<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.8,136.42649684615384,148.0529936923077,159.67949053846155,171.30598738461538,182.9324842307692,194.5589810769231,206.18547792307692,217.81197476923074,229.4384716153846,241.06496846153846,252.69146530769228,264.31796215384617,{"y":275.944459,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.8,130.0866416851923,135.3732833703846,140.6599250555769,145.9465667407692,151.23320842596152,156.51985011115383,161.80649179634614,167.09313348153844,172.37977516673075,177.66641685192306,182.95305853711537,188.23970022230768,{"y":193.52634190749998,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,124.8,125.5010940576923,126.20218811538462,126.90328217307692,127.60437623076923,128.30547028846152,129.00656434615385,129.70765840384615,130.40875246153846,131.10984651923076,131.81094057692306,132.5120346346154,133.2131286923077,{"y":133.91422275,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":124.8,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":124.8,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$275.94Average Price Target$193.53Lowest Price Target$133.91
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:VEE
Alexei Gogolev
J.P. Morgan
J.P. Morgan
CHF240.23→CHF220.76
Buy
―
Reiterated
06/25/26
Veeva price target lowered to $272 from $296 at JPMorganVeeva price target lowered to $272 from $296 at JPMorgan
William Blair Analyst forecast on CH:VEE
Dylan Becker
William Blair
William Blair
―
Buy
―
Reiterated
06/23/26
Veeva Buy Rating Reaffirmed on Strategic Copli Acquisition and Expansion of Intelligent Falcon MLR Platform
Wells Fargo Analyst forecast on CH:VEE
Stan Berenshteyn
Wells Fargo
Wells Fargo
CHF259.71
Buy
―
Reiterated
06/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:VEE
Karl Keirstead
UBS
UBS
CHF178.55→CHF154.2
Hold
―
Assigned
06/04/26
Veeva price target lowered to $190 from $220 at UBSVeeva price target lowered to $190 from $220 at UBS
Robert W. Baird Analyst forecast on CH:VEE
Joseph Vruwink
Robert W. Baird
Robert W. Baird
CHF202.9→CHF211.02
Buy
―
Reiterated
06/04/26
Veeva price target raised to $260 from $250 at BairdVeeva price target raised to $260 from $250 at Baird
Barclays Analyst forecast on CH:VEE
Saket Kalia
Barclays
Barclays
CHF202.9→CHF190.73
Buy
―
Assigned
06/04/26
Veeva Systems (VEEV) Receives a Buy from Barclays
Morgan Stanley Analyst forecast on CH:VEE
Craig Hettenbach
Morgan Stanley
Morgan Stanley
CHF166.38→CHF174.49
Hold
―
Reiterated
06/04/26
Analysts Conflicted on These Healthcare Names: Tenaya Therapeutics (NASDAQ: TNYA), IN8bio (NASDAQ: INAB) and Veeva Systems (NYSE: VEEV)
TD Cowen Analyst forecast on CH:VEE
Charles Rhyee
TD Cowen
TD Cowen
CHF243.48→CHF190.73
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV), Mineralys Therapeutics, Inc. (NASDAQ: MLYS) and ArriVent BioPharma, Inc. (NASDAQ: AVBP)
Evercore ISI Analyst forecast on CH:VEE
Kirk Materne
Evercore ISI
Evercore ISI
CHF194.78→CHF150.15
Hold
―
Reiterated
06/04/26
Veeva price target lowered to $185 from $240 at Evercore ISIVeeva price target lowered to $185 from $240 at Evercore ISI
Oppenheimer Analyst forecast on CH:VEE
Kenneth Wong
Oppenheimer
Oppenheimer
CHF182.61
Buy
―
Reiterated
06/04/26
Oppenheimer Reaffirms Their Buy Rating on Veeva Systems (VEEV)
Stifel Nicolaus Analyst forecast on CH:VEE
David Grossman
Stifel Nicolaus
Stifel Nicolaus
CHF198.84→CHF186.67
Buy
―
Assigned
06/04/26
Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus
Goldman Sachs Analyst forecast on CH:VEE
Adam Hotchkiss
Goldman Sachs
Goldman Sachs
CHF154.2→CHF133.91
Sell
―
Reiterated
06/04/26
Veeva price target lowered to $165 from $190 at Goldman SachsVeeva price target lowered to $165 from $190 at Goldman Sachs
RBC Capital Analyst forecast on CH:VEE
Rishi Jaluria
RBC Capital
RBC Capital
CHF223.19
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Aligos Therapeutics (NASDAQ: ALGS)
Piper Sandler Analyst forecast on CH:VEE
Hannah Rudoff
Piper Sandler
Piper Sandler
CHF231.31→CHF190.73
Buy
―
Reiterated
06/04/26
Veeva price target lowered to $235 from $285 at Piper SandlerVeeva price target lowered to $235 from $285 at Piper Sandler
Truist Financial Analyst forecast on CH:VEE
Jailendra Singh
Truist Financial
Truist Financial
CHF212.64
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (NASDAQ: RVMD) and Veeva Systems (NYSE: VEEV)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:VEE
Alexei Gogolev
J.P. Morgan
J.P. Morgan
CHF240.23→CHF220.76
Buy
―
Reiterated
06/25/26
Veeva price target lowered to $272 from $296 at JPMorganVeeva price target lowered to $272 from $296 at JPMorgan
William Blair Analyst forecast on CH:VEE
Dylan Becker
William Blair
William Blair
―
Buy
―
Reiterated
06/23/26
Veeva Buy Rating Reaffirmed on Strategic Copli Acquisition and Expansion of Intelligent Falcon MLR Platform
Wells Fargo Analyst forecast on CH:VEE
Stan Berenshteyn
Wells Fargo
Wells Fargo
CHF259.71
Buy
―
Reiterated
06/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
UBS Analyst forecast on CH:VEE
Karl Keirstead
UBS
UBS
CHF178.55→CHF154.2
Hold
―
Assigned
06/04/26
Veeva price target lowered to $190 from $220 at UBSVeeva price target lowered to $190 from $220 at UBS
Robert W. Baird Analyst forecast on CH:VEE
Joseph Vruwink
Robert W. Baird
Robert W. Baird
CHF202.9→CHF211.02
Buy
―
Reiterated
06/04/26
Veeva price target raised to $260 from $250 at BairdVeeva price target raised to $260 from $250 at Baird
Barclays Analyst forecast on CH:VEE
Saket Kalia
Barclays
Barclays
CHF202.9→CHF190.73
Buy
―
Assigned
06/04/26
Veeva Systems (VEEV) Receives a Buy from Barclays
Morgan Stanley Analyst forecast on CH:VEE
Craig Hettenbach
Morgan Stanley
Morgan Stanley
CHF166.38→CHF174.49
Hold
―
Reiterated
06/04/26
Analysts Conflicted on These Healthcare Names: Tenaya Therapeutics (NASDAQ: TNYA), IN8bio (NASDAQ: INAB) and Veeva Systems (NYSE: VEEV)
TD Cowen Analyst forecast on CH:VEE
Charles Rhyee
TD Cowen
TD Cowen
CHF243.48→CHF190.73
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV), Mineralys Therapeutics, Inc. (NASDAQ: MLYS) and ArriVent BioPharma, Inc. (NASDAQ: AVBP)
Evercore ISI Analyst forecast on CH:VEE
Kirk Materne
Evercore ISI
Evercore ISI
CHF194.78→CHF150.15
Hold
―
Reiterated
06/04/26
Veeva price target lowered to $185 from $240 at Evercore ISIVeeva price target lowered to $185 from $240 at Evercore ISI
Oppenheimer Analyst forecast on CH:VEE
Kenneth Wong
Oppenheimer
Oppenheimer
CHF182.61
Buy
―
Reiterated
06/04/26
Oppenheimer Reaffirms Their Buy Rating on Veeva Systems (VEEV)
Stifel Nicolaus Analyst forecast on CH:VEE
David Grossman
Stifel Nicolaus
Stifel Nicolaus
CHF198.84→CHF186.67
Buy
―
Assigned
06/04/26
Veeva Systems (VEEV) Receives a Buy from Stifel Nicolaus
Goldman Sachs Analyst forecast on CH:VEE
Adam Hotchkiss
Goldman Sachs
Goldman Sachs
CHF154.2→CHF133.91
Sell
―
Reiterated
06/04/26
Veeva price target lowered to $165 from $190 at Goldman SachsVeeva price target lowered to $165 from $190 at Goldman Sachs
RBC Capital Analyst forecast on CH:VEE
Rishi Jaluria
RBC Capital
RBC Capital
CHF223.19
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Veeva Systems (NYSE: VEEV) and Aligos Therapeutics (NASDAQ: ALGS)
Piper Sandler Analyst forecast on CH:VEE
Hannah Rudoff
Piper Sandler
Piper Sandler
CHF231.31→CHF190.73
Buy
―
Reiterated
06/04/26
Veeva price target lowered to $235 from $285 at Piper SandlerVeeva price target lowered to $235 from $285 at Piper Sandler
Truist Financial Analyst forecast on CH:VEE
Jailendra Singh
Truist Financial
Truist Financial
CHF212.64
Buy
―
Reiterated
06/04/26
Analysts Offer Insights on Healthcare Companies: Revolution Medicines (NASDAQ: RVMD) and Veeva Systems (NYSE: VEEV)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Veeva Systems

3 Months
Joseph VruwinkRobert W. Baird
Success Rate
23/39 ratings generated profit
59%
Average Return
+4.34%
Copying Joseph Vruwink's trades and holding each position for 3 Months would result in 58.97% of your transactions generating a profit, with an average return of +4.34% per trade.
1 Year
Kenneth WongOppenheimer
Success Rate
28/48 ratings generated profit
58%
Average Return
+13.18%
Copying Kenneth Wong's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of +13.18% per trade.
2 Years
Kenneth WongOppenheimer
Success Rate
20/48 ratings generated profit
42%
Average Return
+11.42%
Copying Kenneth Wong's trades and holding each position for 2 Years would result in 41.67% of your transactions generating a profit, with an average return of +11.42% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

VEE Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
4
12
12
11
10
Buy
9
19
15
13
13
Hold
3
8
9
7
8
Sell
3
3
1
1
1
Strong Sell
0
0
0
0
0
total
19
42
37
32
32
In the current month, VEE has received 23 Buy Ratings, 8 Hold Ratings, and 1 Sell Ratings. VEE average Analyst price target in the past 3 months is 193.53.
Each month's total comprises the sum of three months' worth of ratings.

VEE Financial Forecast

VEE Earnings Forecast

Next quarter’s earnings estimate for VEE is $1.80 with a range of $1.78 to $1.84. The previous quarter’s EPS was $1.82. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.
Next quarter’s earnings estimate for VEE is $1.80 with a range of $1.78 to $1.84. The previous quarter’s EPS was $1.82. VEE beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Sales Forecast

Next quarter’s sales forecast for VEE is $733.96M with a range of $731.50M to $745.19M. The previous quarter’s sales results were $715.74M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.
Next quarter’s sales forecast for VEE is $733.96M with a range of $731.50M to $745.19M. The previous quarter’s sales results were $715.74M. VEE beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VEE has Performed in-line its overall industry.

VEE Stock Forecast FAQ

What is CH:VEE’s average 12-month price target, according to analysts?
Based on analyst ratings, Veeva Systems Inc’s 12-month average price target is 193.53.
    What is CH:VEE’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:VEE, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Veeva Systems Inc a Buy, Sell or Hold?
        Veeva Systems Inc has a consensus rating of Moderate Buy, which is based on 15 buy ratings, 6 hold ratings and 1 sell ratings.
          What is Veeva Systems Inc’s share price target?
          The average share price target for Veeva Systems Inc is 193.53. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is $275.94 ,and the lowest forecast is $133.91. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Veeva Systems Inc?
            Veeva Systems Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.
              How can I buy shares of Veeva Systems Inc?
              To buy shares of CH:VEE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.